Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Glycosmedia is dedicated to bringing free, non-promotional, editorially independent news to a global audience about developments in diabetes, and is primarily aimed at health professionals.


Association of glycemia with insulin sensitivity and β-cell function in adults with early type 2 diabetes on metformin alone

April 7th 2021

Glycemia is strongly associated with β-cell dysfunction in adults with early T2DM treated with metformin alone. Efforts to improve glycemia should focus on interventions aimed at improving β-cell function (Journal of Diabetes and Its Complications)

Categories: News, Pathology
Tags: glycaemic control, metformin, Type 2 Diabetes, β-cell

Categories: Pathology
Tags: glycaemic control, metformin, Type 2 Diabetes, β-cell

Early markers of periodontal disease and altered oral microbiota are associated with glycemic control in children with type 1 diabetes

April 7th 2021

Children with type 1 diabetes showed a continuous relationship between less favorable glycemic control and increased early markers of periodontal disease. Glycemic control was also related to the complexity and richness of the plaque microbiota, with diversity increasing as HbA1c levels increase (Pediatric Diabetes)

Categories: News, Pathology
Tags: periodontal, Type 1 Diabetes

Categories: Pathology
Tags: periodontal, Type 1 Diabetes

Pedobarographic Statistical Parametric Mapping may identify specific plantar pressure patterns in patients with diabetes mellitus among different degrees of peripheral neuropathy: a pilot study

April 6th 2021

pSPM may identify specific features of plantar pressure distribution during walking in patients with mild PN and may become a useful screening tool for a timely identification of this complication  (Diabetic Medicine)

Categories: Neuropathy, News
Tags: pedobarographic

Categories: Neuropathy
Tags: pedobarographic

Intrahepatic cholestasis of pregnancy: association with glycaemic control in gestational diabetes

April 6th 2021

Under the current treatment guidelines, ICP is not associated with clinically significant changes in glycaemic control in GDM. Significantly more women with both GDM and ICP developed preeclampsia (Diabetic Medicine)

Categories: Gestational, News
Tags: cholestasis, preeclampsia

Categories: Gestational
Tags: cholestasis, preeclampsia

The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study

April 5th 2021

Among elderly patients with type 2 diabetes, CV reflected TBR ≥ 1% most appropriately among the GV indices examined (Diabetology & Metabolic Syndrome)

Categories: Monitoring, News
Tags: glycemic variability, hypoglycemia, Type 2 Diabetes

Categories: Monitoring
Tags: glycemic variability, hypoglycemia, Type 2 Diabetes

Abnormal N-Glycosylation of Human Lens Epithelial Cells in Type-2 Diabetes May Contribute to Cataract Progression

April 1st 2021

These results suggest that over-expression of N-glycosidically linked human type 1 cytokeratin may induce capsule disruption and affect selective permeability, allowing the entry of different molecules to the lens that facilitate cataract progression (Clinical Ophthalmology)

Categories: News, Ophthalmology
Tags: cataract, Type 2 Diabetes

Categories: Ophthalmology
Tags: cataract, Type 2 Diabetes

Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

March 31st 2021

In the context of the COVID-19 pandemic, there is no clear indication to change prescribing of glucose-lowering drugs in people with type 2 diabetes (Lancet)

Categories: Medication, News, Pathology
Tags: COVID-19, Type 2 Diabetes

Categories: Medication, Pathology
Tags: COVID-19, Type 2 Diabetes

Type 1 diabetes in adults: diagnosis and management (update)

March 31st 2021

In development [GID-NG10159] Expected publication date: 21 July 2021. A list of downloadable documents created during development (NICE)

Categories: Audits, News
Tags: Type 1 Diabetes

Categories: Audits
Tags: Type 1 Diabetes

Insulin Metrics: Need for Development of Consensus Standards for Reporting of Insulin Dosing Data

March 30th 2021

There is an urgent need for the diabetes community to work toward developing a consensus regarding the most effective methods to characterize and report insulin dosing data and to integrate insulin and glucose data reports (Diabetes Technology & Therapeutics)

Categories: Medication, News
Tags: insulin

Categories: Medication
Tags: insulin

Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus

March 25th 2021

These findings indicated that SGLT2 inhibitors can lower serum asprosin levels and improve glucolipid and weight in patients with newly diagnosed T2DM, which may benefit the cardiovascular system (Diabetology & Metabolic Syndrome)

Categories: Medication, News
Tags: asprosin, SGLT2 inhibitors, Type 2 Diabetes

Categories: Medication
Tags: asprosin, SGLT2 inhibitors, Type 2 Diabetes

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

March 24th 2021

Among adults with overweight or obesity who completed a 20-week run-in period with subcutaneous semaglutide, 2.4 mg once weekly, maintaining treatment with semaglutide compared with switching to placebo resulted in continued weight loss over the following 48 weeks (JAMA)

Categories: News, Obesity
Tags: semaglutide

Categories: Obesity
Tags: semaglutide

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

March 23rd 2021

This observational study suggests that treatment with GLP-1RA and SGLT-2i result in very similar cardiorenal outcomes. In the short term, treatment with GLP-1RA seem to be associated with lower risks of stroke and peripheral artery disease, whereas SGLT-2i seem to be nominally associated with lower risk of heart failure and total mortality (Cardiovascular Diabetology)

Categories: Medication, News
Tags: GLP-1 receptor agonists, SGLT2 inhibitors, Type 2 Diabetes

Categories: Medication
Tags: GLP-1 receptor agonists, SGLT2 inhibitors, Type 2 Diabetes

Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1)

March 22nd 2021

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial (Diabetes Care)

Categories: Medication
Tags: Imeglimin, Type 2 Diabetes

Metformin and health outcomes: An umbrella review of systematic reviews with meta‐analyses

March 17th 2021

Observational evidence on metformin seems largely unreliable. Randomized evidence shows benefits for preventing diabetes and in some gynaecological and obstetrical settings. However, almost all meta‐analyses are of low or critically low quality according to AMSTAR 2 criteria (European Journal of Clinical Investigation)

Categories: Medication, News
Tags: metformin

Categories: Medication
Tags: metformin

The All‐Wales Medicines Strategy Group: 18 years’ experience of a National Medicines Optimisation Committee

March 14th 2021

Since 2002, AWMSG has acted as a national medicines optimisation committee in Wales. From the outset, pharmacists and clinical pharmacologists have collaborated closely and shared their complementary expertise to make a much greater contribution to the safe, effective, and cost‐effective use of medicines than either group could have achieved by working separately (British Journal of Clinical Pharmacology)

Categories: Audits, Medication, News, Pharmacology
Tags: AWMSG, Wales

Categories: Audits, Medication, Pharmacology
Tags: AWMSG, Wales

Increased frequency of β cells with abnormal NKX6.1 expression in type 2 diabetes but not in subjects with higher risk for type 2 diabetes

March 14th 2021

Our results suggested that NKX6.1 expression in β cells was changed in type 2 diabetic subjects, evidenced by significantly increased NKX6.1Nuc-Ins+ and NKX6.1cytIns− cells. This abnormality did not occur more frequently in subjects with a higher risk for T2DM, suggesting that β cell dedifferentiation might be secondary to the pathological changes in T2DM (BMC Endocrine Disorders)

Categories: Genetics, News

Categories: Genetics

Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes

March 14th 2021

Given the absence of approved therapies for NAFLD-fibrosis, it would be reasonable to initiate specific randomized controlled trials with statins (Metabolism – Clinical and Experimental)

Categories: Hepatology, News
Tags: statin, Type 2 Diabetes

Categories: Hepatology
Tags: statin, Type 2 Diabetes

Approvals of type 2 diabetes drugs tested in cardiovascular outcome trials: a tripartite comparison

March 12th 2021

Regulatory authorities using identical trial data made substantially different decisions regarding both safety and efficacy of hypoglycemic drugs. The differences in initial indication wording between Japan and the other authorities suggest that trial data and T2D are interpreted differently in these regions (British Journal of Clinical Pharmacology)

Categories: Cardiovascular, Medication, News, Research
Tags: trials, Type 2 Diabetes

Categories: Cardiovascular, Medication, Research
Tags: trials, Type 2 Diabetes

Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes

March 12th 2021

Compared with Whites, Asians may derive greater CV death/HHF benefit from SGLT2is in patients with HFrEF, and MACE benefit from GLP-1RAs in patients with type 2 diabetes (Diabetes Care)

Categories: Cardiovascular, Medication, News
Tags: Asian, GLP-1RA, SGLT2 inhibitors

Categories: Cardiovascular, Medication
Tags: Asian, GLP-1RA, SGLT2 inhibitors

Low‐density lipoprotein cholesterol and lifespan: a Mendelian randomization study

March 12th 2021

This genetic evidence supports that higher LDL‐c levels reduce lifespan and longevity. In a general population that is not selected for increased cardiovascular risk, there is likely a net lifespan benefit of LDL‐c lowering therapies, particularly for PCSK9 inhibitors, although randomized controlled trials are necessary before modification of clinical practice (British Journal of Clinical Pharmacology)

Categories: Medication, News
Tags: LDC

Categories: Medication
Tags: LDC
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 214
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

AstraZenecaNapp DiabetesNovo Nordisk

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

News Archive

calendar-iconNews Archive ››

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 elderly Empagliflozin exenatide GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes USA Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Recent Book and Product Reviews

  • Oxford Handbook of Paediatrics – 3rd Edition
  • Harrison’s Principles of Internal Medicine,
  • Sleisenger and Fordtran’s Gastrointestinal and Liver Disease
  • Family Historian 7

Recent Diabetes Updates

  • National Diabetes Audit.
  • Funding bids
  • Publication of Studies During 2016 – Type 2 Diabetes
  • “Attitudes to obesity” findings from the 2015 survey

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


Website by Wired up Wales

Copyright © 2021 Glycosmedia Partnership